Non-invasive and radiation-free assessment for early rule-out of significant CAD.
Follow us on LinkedIn and Twitter for updates & Acarix News
On a Mission to Listen to Millions of Hearts
Introducing CADScor®System — an AI-powered acoustic diagnostic aid to rule out significant coronary artery disease in 10 minutes.*
Use CADScor®System to Rule-Out Significant CAD in Patients Experiencing Chest Pain or Shortness of Breath*
Can help save costs of more advanced CAD diagnostics in up to 35% of patients.¹
Rapid and easy-to-use, with clear results in 10 minutes.
Rule-Out significant CAD in Just 10 Minutes with at least 96% Confidence (Negative Predictive Value)¹
CADScor®System is a point-of-care diagnostic aid that uses highly sensitive acoustics and advanced AI to analyze the patient's coronary blood flow.² In just 10 minutes, it calculates a patient-specific CAD-score, and couples it with risk factors to indicate the patient’s risk of significant coronary stenosis. CADScor®System has been used in over 24,000 patient assessments³ and has CE-marking and FDA De Novo clearance.
Physicians’ Experiences Using CADScor®System
Explore customer feedbackSchedule a Demo of CADScor®System
Schedule a free demo of CADScor®System and learn how to rule out significant CAD patients in 10 minutes.
Latest News
See all news
November 24, 2022
Helen Ljungdahl Round, CEO of Acarix Presents at Redeye Life Science Day 2022.
November 16, 2022
Acarix publishes Q3 2022 report.
September 26, 2022
Acarix and the American College of Cardiology announce strategic collaboration.
- User manual US-FDA v.12.Y, prevalence 10,7%
- Winther S, et al. Heart 2018;104:928–935 (Dan-NICAD I)
- Based on commercial patch use since 2017